395 related articles for article (PubMed ID: 27462115)
1. Identification of Reversible Disruption of the Human Blood-Brain Barrier Following Acute Ischemia.
Simpkins AN; Dias C; Leigh R;
Stroke; 2016 Sep; 47(9):2405-8. PubMed ID: 27462115
[TBL] [Abstract][Full Text] [Related]
2. Effects of tissue plasminogen activator timing on blood-brain barrier permeability and hemorrhagic transformation in rats with transient ischemic stroke.
Zhang Y; Wang Y; Zuo Z; Wang Z; Roy J; Hou Q; Tong E; Hoffmann A; Sperberg E; Bredno J; Berr SS; Xie M; Lee K; Wintermark M
J Neurol Sci; 2014 Dec; 347(1-2):148-54. PubMed ID: 25292413
[TBL] [Abstract][Full Text] [Related]
3. Pretreatment blood-brain barrier damage and post-treatment intracranial hemorrhage in patients receiving intravenous tissue-type plasminogen activator.
Leigh R; Jen SS; Hillis AE; Krakauer JW; Barker PB;
Stroke; 2014 Jul; 45(7):2030-5. PubMed ID: 24876245
[TBL] [Abstract][Full Text] [Related]
4. Reduced Severity of Tissue Injury Within the Infarct May Partially Mediate the Benefit of Reperfusion in Ischemic Stroke.
Ng FC; Churilov L; Yassi N; Kleinig TJ; Thijs V; Wu TY; Shah DG; Dewey HM; Sharma G; Desmond PM; Yan B; Parsons MW; Donnan GA; Davis SM; Mitchell PJ; Leigh R; Campbell BCV;
Stroke; 2022 Jun; 53(6):1915-1923. PubMed ID: 35135319
[TBL] [Abstract][Full Text] [Related]
5. Frequency of Blood-Brain Barrier Disruption Post-Endovascular Therapy and Multiple Thrombectomy Passes in Acute Ischemic Stroke Patients.
Luby M; Hsia AW; Nadareishvili Z; Cullison K; Pednekar N; Adil MM; Latour LL
Stroke; 2019 Aug; 50(8):2241-2244. PubMed ID: 31238832
[TBL] [Abstract][Full Text] [Related]
6. Should we exclude acute stroke patients with previous intracerebral hemorrhage from receiving intravenous thrombolysis?
Lee SH; Kim BJ; Han MK; Park TH; Lee KB; Lee BC; Yu KH; Oh MS; Cha JK; Kim DH; Nah HW; Lee J; Lee SJ; Ko Y; Kim JG; Park JM; Kang K; Cho YJ; Hong KS; Choi JC; Kim JT; Choi K; Kim DE; Ryu WS; Kim WJ; Shin DI; Yeo M; Lee J; Lee JS; Gorelick PB; Bae HJ
Int J Stroke; 2016 Oct; 11(7):783-90. PubMed ID: 27312681
[TBL] [Abstract][Full Text] [Related]
7. Two tales: hemorrhagic transformation but not parenchymal hemorrhage after thrombolysis is related to severity and duration of ischemia: MRI study of acute stroke patients treated with intravenous tissue plasminogen activator within 6 hours.
Thomalla G; Sobesky J; Köhrmann M; Fiebach JB; Fiehler J; Zaro Weber O; Kruetzelmann A; Kucinski T; Rosenkranz M; Röther J; Schellinger PD
Stroke; 2007 Feb; 38(2):313-8. PubMed ID: 17204683
[TBL] [Abstract][Full Text] [Related]
8. Computed Tomography Perfusion Derived Blood-Brain Barrier Permeability Does Not Yet Improve Prediction of Hemorrhagic Transformation.
Horsch AD; Bennink E; van Seeters T; Kappelle LJ; van der Graaf Y; Mali WPTM; de Jong HWAM; Velthuis BK; Dankbaar JW;
Cerebrovasc Dis; 2018; 45(1-2):26-32. PubMed ID: 29402765
[TBL] [Abstract][Full Text] [Related]
9. Blood-brain barrier integrity of stroke patients presenting in an extended time window.
Butler J; Heidari P; Blayney S; Hitomi E; Luby M; Leigh R
BMC Neurol; 2020 Feb; 20(1):54. PubMed ID: 32054451
[TBL] [Abstract][Full Text] [Related]
10. Focal Low and Global High Permeability Predict the Possibility, Risk, and Location of Hemorrhagic Transformation following Intra-Arterial Thrombolysis Therapy in Acute Stroke.
Li Y; Xia Y; Chen H; Liu N; Jackson A; Wintermark M; Zhang Y; Hu J; Wu B; Zhang W; Tu J; Su Z; Zhu G
AJNR Am J Neuroradiol; 2017 Sep; 38(9):1730-1736. PubMed ID: 28705822
[TBL] [Abstract][Full Text] [Related]
11. The Efficacy of IV Tissue Plasminogen Activator for Restoring Cerebral Blood Flow in the Hours Immediately after Administration in Patients with Acute Stroke.
Majidi S; Simpkins AN; Leigh R;
J Neuroimaging; 2019 Mar; 29(2):206-210. PubMed ID: 30508260
[TBL] [Abstract][Full Text] [Related]
12. Early Blood-Brain Barrier Disruption after Mechanical Thrombectomy in Acute Ischemic Stroke.
Shi ZS; Duckwiler GR; Jahan R; Tateshima S; Szeder V; Saver JL; Kim D; Sharma LK; Vespa PM; Salamon N; Villablanca JP; Viñuela F; Feng L; Loh Y; Liebeskind DS
J Neuroimaging; 2018 May; 28(3):283-288. PubMed ID: 29484769
[TBL] [Abstract][Full Text] [Related]
13. Normobaric hyperoxia slows blood-brain barrier damage and expands the therapeutic time window for tissue-type plasminogen activator treatment in cerebral ischemia.
Liang J; Qi Z; Liu W; Wang P; Shi W; Dong W; Ji X; Luo Y; Liu KJ
Stroke; 2015 May; 46(5):1344-1351. PubMed ID: 25804925
[TBL] [Abstract][Full Text] [Related]
14. Worse stroke outcome in atrial fibrillation is explained by more severe hypoperfusion, infarct growth, and hemorrhagic transformation.
Tu HT; Campbell BC; Christensen S; Desmond PM; De Silva DA; Parsons MW; Churilov L; Lansberg MG; Mlynash M; Olivot JM; Straka M; Bammer R; Albers GW; Donnan GA; Davis SM;
Int J Stroke; 2015 Jun; 10(4):534-40. PubMed ID: 23489996
[TBL] [Abstract][Full Text] [Related]
15. Evidence of reperfusion injury, exacerbated by thrombolytic therapy, in human focal brain ischemia using a novel imaging marker of early blood-brain barrier disruption.
Warach S; Latour LL
Stroke; 2004 Nov; 35(11 Suppl 1):2659-61. PubMed ID: 15472105
[TBL] [Abstract][Full Text] [Related]
16. Blood-brain barrier permeability assessed by perfusion computed tomography predicts hemorrhagic transformation in acute reperfusion therapy.
Kim T; Koo J; Kim SH; Song IU; Chung SW; Lee KS
Neurol Sci; 2018 Sep; 39(9):1579-1584. PubMed ID: 29909558
[TBL] [Abstract][Full Text] [Related]
17. Early blood-brain barrier disruption in human focal brain ischemia.
Latour LL; Kang DW; Ezzeddine MA; Chalela JA; Warach S
Ann Neurol; 2004 Oct; 56(4):468-77. PubMed ID: 15389899
[TBL] [Abstract][Full Text] [Related]
18. Permeable Thrombi Are Associated With Higher Intravenous Recombinant Tissue-Type Plasminogen Activator Treatment Success in Patients With Acute Ischemic Stroke.
Santos EM; Dankbaar JW; Treurniet KM; Horsch AD; Roos YB; Kappelle LJ; Niessen WJ; Majoie CB; Velthuis B; Marquering HA;
Stroke; 2016 Aug; 47(8):2058-65. PubMed ID: 27338928
[TBL] [Abstract][Full Text] [Related]
19. Quantitative MRI reveals the elderly ischemic brain is susceptible to increased early blood-brain barrier permeability following tissue plasminogen activator related to claudin 5 and occludin disassembly.
Kaur J; Tuor UI; Zhao Z; Barber PA
J Cereb Blood Flow Metab; 2011 Sep; 31(9):1874-85. PubMed ID: 21610723
[TBL] [Abstract][Full Text] [Related]
20. Pinocembrin Protects Blood-Brain Barrier Function and Expands the Therapeutic Time Window for Tissue-Type Plasminogen Activator Treatment in a Rat Thromboembolic Stroke Model.
Ma Y; Li L; Kong L; Zhu Z; Zhang W; Song J; Chang J; Du G
Biomed Res Int; 2018; 2018():8943210. PubMed ID: 29850586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
